Skip to Content

RESPA 787 (Respa-PE 600 mg / 18 mg)

Pill with imprint RESPA 787 is White, Elliptical / Oval and has been identified as Respa-PE 600 mg / 18 mg. It is supplied by Respa Pharmaceuticals.

Guaifenesin/phenylephrine is used in the treatment of sinus symptoms; cough and nasal congestion and belongs to the drug class upper respiratory combinations. Risk cannot be ruled out during pregnancy. Guaifenesin/phenylephrine 600 mg / 18 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for RESPA 787

Respa-PE

Imprint
RESPA 787
Strength
600 mg / 18 mg
Color
White
Shape
Elliptical / Oval
Availability
Rx and/or OTC
Drug Class
Upper respiratory combinations
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Respa Pharmaceuticals
National Drug Code (NDC)
60575-0787

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.